186 related articles for article (PubMed ID: 11464216)
1. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway.
Decker RH; Dai Y; Grant S
Cell Death Differ; 2001 Jul; 8(7):715-24. PubMed ID: 11464216
[TBL] [Abstract][Full Text] [Related]
2. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
3. c-IAP1 blocks TNFalpha-mediated cytotoxicity upstream of caspase-dependent and -independent mitochondrial events in human leukemic cells.
Partheniou F; Kelsey SM; Srinivasula SM; Newland AC; Alnemri ES; Jia L
Biochem Biophys Res Commun; 2001 Sep; 287(1):181-9. PubMed ID: 11549272
[TBL] [Abstract][Full Text] [Related]
4. Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA).
Almenara J; Rosato R; Grant S
Leukemia; 2002 Jul; 16(7):1331-43. PubMed ID: 12094258
[TBL] [Abstract][Full Text] [Related]
5. Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells.
Yu C; Krystal G; Dent P; Grant S
Clin Cancer Res; 2002 Sep; 8(9):2976-84. PubMed ID: 12231544
[TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
Rosato RR; Almenara JA; Grant S
Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953
[TBL] [Abstract][Full Text] [Related]
7. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis.
Perkins CL; Fang G; Kim CN; Bhalla KN
Cancer Res; 2000 Mar; 60(6):1645-53. PubMed ID: 10749135
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S
Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557
[TBL] [Abstract][Full Text] [Related]
9. Alsterpaullone, a novel cyclin-dependent kinase inhibitor, induces apoptosis by activation of caspase-9 due to perturbation in mitochondrial membrane potential.
Lahusen T; De Siervi A; Kunick C; Senderowicz AM
Mol Carcinog; 2003 Apr; 36(4):183-94. PubMed ID: 12669310
[TBL] [Abstract][Full Text] [Related]
10. Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol.
Rosato RR; Almenara JA; Yu C; Grant S
Mol Pharmacol; 2004 Mar; 65(3):571-81. PubMed ID: 14978235
[TBL] [Abstract][Full Text] [Related]
11. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
Wu SJ; Ng LT; Lin CC
Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
[TBL] [Abstract][Full Text] [Related]
12. MT-21 is a synthetic apoptosis inducer that directly induces cytochrome c release from mitochondria.
Watabe M; Machida K; Osada H
Cancer Res; 2000 Sep; 60(18):5214-22. PubMed ID: 11016650
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.
von Haefen C; Wieder T; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2003 Apr; 22(15):2236-47. PubMed ID: 12700660
[TBL] [Abstract][Full Text] [Related]
14. Granzyme B-induced loss of mitochondrial inner membrane potential (Delta Psi m) and cytochrome c release are caspase independent.
Heibein JA; Barry M; Motyka B; Bleackley RC
J Immunol; 1999 Nov; 163(9):4683-93. PubMed ID: 10528165
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial cytochrome c release is caspase-dependent and does not involve mitochondrial permeability transition in didemnin B-induced apoptosis.
Grubb DR; Ly JD; Vaillant F; Johnson KL; Lawen A
Oncogene; 2001 Jul; 20(30):4085-94. PubMed ID: 11494136
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascade.
Ko CH; Shen SC; Hsu CS; Chen YC
Biochem Pharmacol; 2005 Mar; 69(6):913-27. PubMed ID: 15748703
[TBL] [Abstract][Full Text] [Related]
17. Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells.
Chen J; Mehta JL; Haider N; Zhang X; Narula J; Li D
Circ Res; 2004 Feb; 94(3):370-6. PubMed ID: 14684629
[TBL] [Abstract][Full Text] [Related]
18. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
20. The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cells.
Rosato RR; Almenara JA; Cartee L; Betts V; Chellappan SP; Grant S
Mol Cancer Ther; 2002 Feb; 1(4):253-66. PubMed ID: 12467221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
